Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Single chain antibody variable regions.

R E Bird1, B W Walker

  • 1Molecular Oncology, Inc., Gaithersburg, MD 20878.

Trends in Biotechnology
|April 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Solar spectral measurements in the terrestrial environment.

Applied optics·2010
Same author

Reassessment of breast cancers missed during routine screening mammography: a community-based study.

AJR. American journal of roentgenology·2001
Same author

A rapid and simple procedure to detect the presence of MVM in conditioned cell fluids or culture media.

Biologicals : journal of the International Association of Biological Standardization·1998
Same author

Placement of endovascular embolization microcoils to localize the site of breast lesions removed at stereotactic core biopsy.

Radiology·1998
Same author

Image-guided core biopsy has advantages over needle localization biopsy for the diagnosis of nonpalpable breast cancer.

The American surgeon·1997
Same author

Development of an improved product enhanced reverse transcriptase assay.

Journal of virological methods·1997
Same journal

Bacterial spores as a modular platform for the production of amyloids for materials.

Trends in biotechnology·2026
Same journal

The oriGen case and Mexico's regulatory blind spots in genomic biobanking.

Trends in biotechnology·2026
Same journal

A caspase-3-activated protein expression system for apoptosis visualization and apoptosis-pyroptosis conversion to boost antitumor activity.

Trends in biotechnology·2026
Same journal

Over 4 months of ethylene production using solid-state photosynthetic cell factories.

Trends in biotechnology·2026
Same journal

Closing the nitrogen loop in groundwater with biohybrid technologies.

Trends in biotechnology·2026
Same journal

Engineering environmental bacteria for whole-cell PET hydrolysis and assimilation.

Trends in biotechnology·2026
See all related articles

Antibody fragments face challenges in tumor targeting. A new method links antibody variable fragments (Fvs) into single-chain variable fragments (scFvs) for improved tumor targeting and easier production.

Area of Science:

  • Biotechnology
  • Immunology
  • Oncology

Background:

  • Antibodies and antibody fragments are used for tumor targeting in imaging and therapy.
  • Clinical trials show limitations including poor clearance and non-specific binding of antibody-based agents.
  • These challenges hinder the efficacy of antibody-based tumor-targeting strategies.

Purpose of the Study:

  • To develop a novel antibody-based approach to overcome limitations in tumor targeting.
  • To improve the efficiency and specificity of antibody fragments for oncological applications.
  • To facilitate large-scale production of engineered antibody fragments.

Main Methods:

  • Linking two antibody variable fragments (Fvs) via a short peptide sequence.
  • Generating a continuous polypeptide chain, forming single-chain variable fragments (scFvs).

Related Experiment Videos

  • Utilizing constructed genes for potential large-scale production, e.g., in E. coli.

    • Main Results:

    • The novel scFv approach offers a potential solution to antibody clearance and binding issues.
    • Engineered scFvs may provide enhanced tumor targeting capabilities.
    • The method allows for straightforward, large-scale production of therapeutic or diagnostic agents.

    Conclusions:

    • Single-chain variable fragments (scFvs) represent a promising advancement in antibody-based tumor targeting.
    • This approach addresses key limitations encountered in previous antibody fragment clinical trials.
    • The potential for scalable production in microbial systems enhances the clinical applicability of scFvs.